In February, we moderated an investment panel at the MoneyShow’s Cannabis Investing Event and met with several industry executives and experts.
The timing of the conference was ideal for attendees that were trying to learn about the evolution and advancement of the industry as well as the companies that are positioned to be capitalize on a long-term growth cycle.
So far this year, the cannabis industry has been under considerable pressure and the trend has similar to the fourth calendar quarter of 2021. Our rationale for the timing of the event being ideal is primarily based on an improved risk-reward profile for leading cannabis operators and want to highlight a company that we spoke with at the MoneyShow’s Cannabis Investing Event.
The company, Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) has been a leading herbal supplement formulator since 1994 and is led by a management team that has a proven track record of success.
During the last year, Irwin’s business model evolved and is leveraging its brand awareness and existing infrastructure to capitalize on the cannabis and psychedelic industries. Since inception, Irwin has become a well-known household brand and its herbal products are available in more than 100,000 retail doors across North America.
A few years ago, Irwin entered the cannabis market and started to sell hemp-based cannabidiol (CBD) products. Since then, the management team has expanded its focus to the tetrahydrocannabinol (THC) side of the sector by licensing its household brand name to licensed third parties that manufacture products that contain THC.
We believe Irwin is one of the few companies to have a large scale consumer base prior to launching a product and consider this to be a unique and attractive aspect of the story. After meeting Irwin Naturals CEO Klee Irwin at the MoneyShow’s Cannabis Investing Event, we became more excited about the potential of the business and believe the opportunity is flying under the radar.
During the last few months, Irwin has performed better than most cannabis stocks. Although volume has been light, we expect the trend to change as the company continues to execute on a multi-faceted growth strategy that is centered around capitalizing on the cannabis and psychedelic sectors.
Over the next year, we expect Irwin to gain more awareness and believe our readers should be aware of the opportunity ahead of this. If you are interested in learning more about Irwin Naturals, please send an email to email@example.com with the subject “Irwin Naturals” to be added to our distribution list.
For the fastest access to data on Irwin Naturals, sign up for our free newsletter!